0001209191-19-043329.txt : 20190726
0001209191-19-043329.hdr.sgml : 20190726
20190726161352
ACCESSION NUMBER: 0001209191-19-043329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190724
FILED AS OF DATE: 20190726
DATE AS OF CHANGE: 20190726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baxter Joel D.
CENTRAL INDEX KEY: 0001666161
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-04851
FILM NUMBER: 19978219
MAIL ADDRESS:
STREET 1: 101 W. PROSPECT AVENUE
CITY: CLEVELAND
STATE: OH
ZIP: 44115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SHERWIN WILLIAMS CO
CENTRAL INDEX KEY: 0000089800
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-BUILDING MATERIALS, HARDWARE, GARDEN SUPPLY [5200]
IRS NUMBER: 340526850
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 PROSPECT AVE NW
CITY: CLEVELAND
STATE: OH
ZIP: 44115
BUSINESS PHONE: 2165662200
MAIL ADDRESS:
STREET 1: 101 PROSPECT AVE NW
CITY: CLEVELAND
STATE: OH
ZIP: 44115
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-24
0
0000089800
SHERWIN WILLIAMS CO
SHW
0001666161
Baxter Joel D.
101 W. PROSPECT AVENUE
CLEVELAND
OH
44115
0
1
0
0
Pres. & GM, Glob. Supply Chain
Common Stock
2019-07-24
4
M
0
6083
239.55
A
8216
D
Common Stock
2019-07-24
4
S
0
600
489.34
D
7616
D
Common Stock
2019-07-24
4
S
0
400
490.61
D
7216
D
Common Stock
2019-07-24
4
S
0
2780
492.36
D
4436
D
Common Stock
2019-07-24
4
S
0
2098
493.07
D
2338
D
Common Stock
2019-07-24
4
S
0
205
495.21
D
2133
D
Common Stock
7209.4
I
Stock Plan
Employee Stock Option (Right to Buy)
239.55
2019-07-24
4
M
0
2167
0.00
D
2016-10-16
2025-10-15
Common Stock
2167
0
D
Employee Stock Option (Right to Buy)
239.55
2019-07-24
4
M
0
2167
0.00
D
2017-10-16
2025-10-15
Common Stock
2167
0
D
Employee Stock Option (Right to Buy)
239.55
2019-07-24
4
M
0
1749
0.00
D
2018-10-16
2025-10-15
Common Stock
1749
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $489.24 to $489.84 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $490.55 to $490.67 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $491.77 to $492.76 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $492.84 to $493.35 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $494.93 to $495.48 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Of shares listed, 1,277 are restricted stock units.
Represents the number of shares of common stock attributable to the reporting person's participation in The Sherwin-Williams Company Employee Stock Purchase and Savings Plan per the trustee's 06/30/2019 statement.
Exhibit 24, Power of Attorney, is attached.
Stephen J. Perisutti, Attorney-in-fact
2019-07-26
EX-24.4_866124
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of John G. Morikis, Allen J. Mistysyn, Mary L. Garceau and Stephen J.
Perisutti, or any of them signing singly, and with full power of substitution,
as the undersigned's true and lawful attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents necessary or appropriate
to
obtain codes and passwords enabling the undersigned to make electronic filings
with the SEC of reports required by Section 16(a) of the Securities Exchange Act
of 1934 or any rule or regulation of the SEC ("Section 16");
(2) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of The Sherwin-Williams Company (the "Company"),
Forms 3, 4, and 5 in accordance with Section 16;
(3) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file any
such form with the SEC and any stock exchange or similar authority; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney in fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or desirable to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to
be done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that
the foregoing attorneys-in-fact, in serving in such capacity at the request of
the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 22nd day of July, 2019.
/s/ Joel D. Baxter